Back to Search

LUCIAN CHIRIEAC, MD

MD

Anatomic Pathology Physician

NPI: 1225064397Individual

Specialties, Licenses & Credentials

Anatomic Pathology PhysicianPrimary

Pathology — Anatomic Pathology

Code: 207ZP0101X

223038(MA)

Research & Publications (20)

Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
PMID 19040416·J Cell Mol Med·2009
8-other
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
PMID 19653732·Arch Pathol Lab Med·2009
6-review
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
PMID 19414679·J Clin Oncol·2009
4-observational
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.
PMID 19671850·Clin Cancer Res·2009
8-other
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
PMID 19667264·J Clin Oncol·2009
8-other
Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.
PMID 19366827·Clin Cancer Res·2009
7-preclinical
A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.
PMID 19185169·J Thorac Cardiovasc Surg·2009
3-trial
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.
PMID 19122144·Proc Natl Acad Sci U S A·2009
7-preclinical
Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis.
PMID 19336729·Cancer Prev Res (Phila)·2009
7-preclinical
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.
PMID 18632637·Cancer Res·2008
7-preclinical
Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
PMID 18720359·Cancer·2008
8-other
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.
PMID 18927287·Clin Cancer Res·2008
7-preclinical
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
PMID 19029981·Nat Med·2008
7-preclinical
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
PMID 18451217·Clin Cancer Res·2008
8-other
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.
PMID 18408761·Oncogene·2008
7-preclinical
Non-small cell lung cancer.
PMID 18377844·J Natl Compr Canc Netw·2008
6-review
Somatic mutations affect key pathways in lung adenocarcinoma.
PMID 18948947·Nature·2008
8-other
Transcriptome sequencing of malignant pleural mesothelioma tumors.
PMID 18303113·Proc Natl Acad Sci U S A·2008
8-other
A microaliquoting technique for precise histological annotation and optimization of cell content in frozen tissue specimens.
PMID 17917854·Biotech Histochem·2007
8-other
Characterizing the cancer genome in lung adenocarcinoma.
PMID 17982442·Nature·2007
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
75 FRANCIS ST, BWH DEPARTMENT OF PATHOLOGY
BOSTON, MA 02112

Location

Practice Location

75 FRANCIS ST, BOSTON, MA
(617) 732-8126

Quick Facts

NPI
1225064397
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile